טוען...
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
BACKGROUND: Recent evidence suggests that immunotherapy efficacy in melanoma is modulated by gut microbiota. Few studies have examined this phenomenon in humans, and none have incorporated metatranscriptomics, important for determining expression of metagenomic functions in the microbial community....
שמור ב:
| הוצא לאור ב: | Genome Med |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785875/ https://ncbi.nlm.nih.gov/pubmed/31597568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-019-0672-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|